Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Revenue | 692M | 512M | 536M | 499M | 440M | 448M |
| Cost of revenue | 91M | 87M | 88M | 88M | 87M | 88M |
| Research and development | 54M | 50M | 47M | 45M | 45M | 44M |
| Selling, general and administrative | 144M | 141M | 139M | 120M | 128M | 125M |
| Operating expenses | 289M | 278M | 274M | 253M | 260M | 258M |
| Operating income | 402M | 234M | 263M | 246M | 180M | 190M |
| Interest expense | — | — | — | 31M | 29M | 27M |
| Pre-tax income | 356M | 192M | 237M | 213M | 150M | 167M |
| Income tax | 92M | 34M | 55M | 50M | −2M | 41M |
| Net income | 264M | 158M | 182M | 163M | 153M | 126M |
| Earnings per share | 11.19 | 6.68 | 7.49 | 6.67 | 6.26 | 5.12 |
| Earnings per share, diluted | 11.14 | 6.61 | 7.40 | 6.59 | 6.14 | 5.05 |
| Weighted average shares | 24M | 24M | 24M | 24M | 24M | 25M |
| Weighted average shares, diluted | 24M | 24M | 25M | 25M | 25M | 25M |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 219M | 162M | 134M | 189M | 147M | 184M | 151M | 156M |
| Receivables | 620M | 495M | 529M |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | — | 174M | — | — | 194M | — |
| Depreciation and amortisation | — | 4M | — |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 454M |
| 493M |
| 351M |
| 427M |
| 438M |
| Current assets | 901M | 699M | 705M | 710M | 725M | 596M | 617M | 631M |
| Property, plant and equipment | — | — | — | — | — | — | 38M | — |
| Goodwill | 781M | 784M | 783M | 785M | 779M | 776M | 783M | 777M |
| Total assets | 2.05B | 1.85B | 1.87B | 1.86B | 1.84B | 1.71B | 1.72B | 1.71B |
| Current liabilities | 405M | 752M | 849M | 771M | 343M | 331M | 380M | 337M |
| Short-term debt | 0 | 400M | 400M | 399M | 15M | 15M | 15M | 15M |
| Long-term debt | 3.64B | 2.80B | 2.66B | 2.38B | 2.51B | 2.41B | 2.19B | 2.10B |
| Total liabilities | 4.15B | 3.66B | 3.61B | 3.26B | 2.96B | 2.84B | 2.68B | 2.54B |
| Equity | −2.10B | −1.81B | −1.75B | −1.40B | −1.12B | −1.14B | −963M | −829M |
| Shares outstanding | 23M | 24M | 24M | 24M | 24M | 24M | 24M | 25M |
| Shares issued | 89M | 89M | 89M | 89M | 89M | 89M | 89M | 89M |
| Treasury shares | 66M | 65M | 65M | 65M | 65M | 64M | 64M | 64M |
| 4M |
| — |
| Share-based compensation | 45M | 44M | 42M | 42M | 41M | 42M |
| Capital expenditure | — | 226,000 | — | — | 841,000 | — |
| Investing cash flow | — | −13M | — | — | −9M | — |
| Share buybacks | — | 171M | — | — | 163M | — |
| Financing cash flow | — | −133M | — | — | −144M | — |